These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature. Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide: current and potential clinical applications. Calabrese L; Fleischer AB Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782 [TBL] [Abstract][Full Text] [Related]
7. [Thalidomide: the revival]. Grosbois B; Duguet C Rev Med Interne; 2001 Jan; 22(1):5-7. PubMed ID: 11218298 [No Abstract] [Full Text] [Related]
8. Thalidomide: rationale for renewed use in immunological disorders. Schuler U; Ehninger G Drug Saf; 1995 Jun; 12(6):364-9. PubMed ID: 8527011 [TBL] [Abstract][Full Text] [Related]
10. Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. Walchner M; Meurer M; Plewig G; Messer G Int J Dermatol; 2000 May; 39(5):383-8. PubMed ID: 10849134 [TBL] [Abstract][Full Text] [Related]
11. Thalidomide: a review of approved and investigational uses. Matthews SJ; McCoy C Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503 [TBL] [Abstract][Full Text] [Related]
12. Review of thalidomide use in the pediatric population. Yang CS; Kim C; Antaya RJ J Am Acad Dermatol; 2015 Apr; 72(4):703-11. PubMed ID: 25617013 [TBL] [Abstract][Full Text] [Related]
13. [Weight gain during treatment with thalidomide: a case report]. Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D Therapie; 2014; 69(5):457-9. PubMed ID: 25285366 [TBL] [Abstract][Full Text] [Related]
14. [Cyclosporin for the treatment of systemic autoimmune diseases]. Tanaka Y Nihon Rinsho; 2005 May; 63 Suppl 5():240-6. PubMed ID: 15954356 [No Abstract] [Full Text] [Related]
15. [Corticosteroid therapy of various systemic diseases (non-neoplastic, noninfectious)]. Sternon J; Decaux G; Nève P Rev Med Brux; 1991 May; 12(5):179-85. PubMed ID: 2057665 [TBL] [Abstract][Full Text] [Related]
16. Thalidomide responsiveness in an infant with Behçet's syndrome. Shek LP; Lee YS; Lee BW; Lehman TJ Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947 [TBL] [Abstract][Full Text] [Related]
17. The effect of thalidomide and 2 analogs on collagen induced arthritis. Oliver SJ; Cheng TP; Banquerigo ML; Brahn E J Rheumatol; 1998 May; 25(5):964-9. PubMed ID: 9598899 [TBL] [Abstract][Full Text] [Related]
18. Sucessful use of thalidomide in severe gastrointestinal Behçet's disease. Lim YK; Keating JP; Steele R ANZ J Surg; 2015 Jun; 85(6):496. PubMed ID: 26031928 [No Abstract] [Full Text] [Related]
19. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Huizinga TW; Dijkmans BA; van der Velde EA; van de Pouw Kraan TC; Verweij CL; Breedveld FC Ann Rheum Dis; 1996 Nov; 55(11):833-6. PubMed ID: 8976641 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature. Ginsburg PM; Dassopoulos T; Ehrenpreis ED Ann Med; 2001 Nov; 33(8):516-25. PubMed ID: 11730158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]